Using plant compounds that potentially block spike protein

Dr. Kreynes has a background in both medical and environmental microbiology as well as molecular biology and plant biochemistry. She completed her Honours Bachelor of Science degree atthe University of Toronto, in 2006, with a specialist in microbiology and a major in botany. Subsequently she moved to British Columbia, to pursue her Master of Science degree at UBC in microbial diversity and evolution (completed in 2008). Finally, she defended her PhD at UBC in plant molecular biology and biochemistry, in 2018.

Anna’s PhD research focused on understanding how environmental signals influence the plant’s ability to produce phytochemical compounds (namely flavonoids and anthocyanins), which are important for human health, as well as plant defense. This experience solidified her earlier interest in plant medicine, particularly the synergistic way in which plant-derived compounds can improve human health and assist in treating chronic illness.

Since the emergence of COVID-19, many plant compounds have been identified as potential blockers of the SPIKE protein. Incidentally, some of these compounds have been traditionally used in treating respiratory illness, as well as some ailments that are currently associated with emerging injuries from the COVID19 mRNA vaccine. The goal of this presentation is to draw attention to such compounds, in order to encourage collaborative research that can expand our arsenal for combating chronic health conditions linked to COVID-19 vaccine injury. A secondary goal of this presentation is to shed light on the relevance of traditional medicine and a need for an interdisciplinary platform in developing new treatment options for chronic disease.